Physician profile
Benjamin Harstine
NPI 1649852997
$315.02
in general payments reported to CMS, 2019-2025
10 companies · $315 in 2025
The $315 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $315.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $85.44 | 2025 | Caplyta |
| Takeda Pharmaceuticals U.S.A., INC. | $58.23 | 2025 | Eohilia |
| Pfizer INC. | $37.95 | 2025 | |
| Novartis Pharmaceuticals Corporation | $32.04 | 2025 | |
| Melinta Therapeutics, LLC | $20.68 | 2025 | Kimyrsa, Rezzayo |
| Lilly USA, LLC | $19.81 | 2025 | Zepbound, Mounjaro |
| Dexcom, INC. | $18.25 | 2025 | Dexcom G6 Transmitter |
| Astellas Pharma US INC | $14.82 | 2025 | Veozah |
| Viatris Specialty LLC | $14.04 | 2025 | Yupelri |
| Electromed, INC. | $13.76 | 2025 | Smartvest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Harstine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.